Landis Communications CEO Sean Dowdall Named 2025 Business of Pride Honoree as Award-Winning Agency Celebrates 35 Years of Impact
SAN FRANCISCO, June 24, 2025 (GLOBE NEWSWIRE) -- Pride month brings extra reason to celebrate for Landis Communications Inc. (Landis), as the San Francisco Business Times (SFBT) has named President and CEO Sean Dowdall a 2025 Outstanding Voices and Business of Pride Honoree. The prestigious recognition highlights LGBTQ+ business leaders who are making a significant difference in their communities and companies – a perfect reflection of Landis' 35-year commitment to purpose-driven communications and community impact.
The Business of Pride honor adds to Dowdall's distinguished record as a leader in both the LGBTQ+ business community and the broader San Francisco Bay Area. Landis has been a multiple-year winner of the SF Business Times' top philanthropy awards and has consistently ranked among the top LGBTQ+ businesses in the San Francisco Bay Area, reinforcing the agency's deep roots in community leadership and social responsibility. Mr. Dowdall reflected upon this moment in a uniquely personal blog entry.
"Being recognized as a Business of Pride Honoree is deeply meaningful, especially during Pride month when we celebrate the progress our community has made while acknowledging the work still ahead," said Dowdall. "This recognition reflects not just my personal journey, but the values that have guided Landis for 35 years – using our platform to amplify voices that matter and create meaningful change in our communities. We are enormously proud to be a values aligned business."
The SFBT recognition comes during a banner year for the award-winning agency. Landis was named to the PRNEWS Agency Elite Top 120 for the fifth consecutive year and ranks among O'Dwyer's top PR firms for 2024. The agency also won PR Daily's national award for Best Nonprofit Campaign, highlighting its leadership in purpose-driven communications.
Adding to its trophy case, the Public Relations Society of America (PRSA) San Francisco chapter awarded Landis the coveted "Standout Tactic of the Year" award for its imaginative and impactful General Sherman campaign for Save the Redwoods League. This award recognizes exceptional creativity and effectiveness in public relations tactics.
Reflecting the agency's continued growth and industry recognition, Landis has recently welcomed six new clients to its roster: Align Surgical Associates, National Rainbow College Fund, Mechanics' Institute, Santa Clara Valley Open Space Authority, Mother's Milk Bank and Western Rivers Conservancy.
"Our success over 35 years has always been rooted in putting our clients first while staying true to our values of community impact and social responsibility," said Dowdall. "As we celebrate this Pride recognition, we're reminded that our work extends beyond traditional PR – we're helping organizations create lasting change and build meaningful connections within the communities they serve."
ABOUT LANDIS COMMUNICATIONS INC. (Landis):
Celebrating 35 years in business, Landis is an award-winning, full-service, integrated public relations, marketing communications, digital and social media agency. The agency offers a unique mix of expertise in healthcare, environmental, corporate, consumer, B2B, B2C, technology, arts/culture and nonprofit marketing communications. Ragan's ACE Awards named Landis America's #1 Small Agency and America's #1 Healthcare PR Agency. Landis also is the San Francisco/Silicon Valley member agency of the Public Relations Global Network, with 50+ agency affiliates worldwide. For further information, visit Landis online.
Contact:
Brianne Murphy Miller650.575.7727brianne@landispr.comwww.landispr.com
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
38 minutes ago
- Yahoo
Sight Sciences to Report Second Quarter 2025 Financial Results on August 7, 2025
MENLO PARK, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ('Sight Sciences' or the 'Company'), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patients' lives, today announced it will report financial results for the second quarter ended June 30, 2025, after the market close on Thursday, August 7, 2025. The Company's management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at on the Investors page in the News & Events section. The webcast will be available for replay for at least 90 days after the event. About Sight Sciences Sight Sciences is an eyecare technology company focused on developing and commercializing innovative and interventional solutions intended to transform care and improve patients' lives. Using minimally invasive or non-invasive approaches to target the underlying causes of the world's most prevalent eye diseases, Sight Sciences seeks to create more effective treatment paradigms that enhance patient care and supplant conventional outdated approaches. The Company's OMNI® Surgical System and OMNI® Edge Surgical System are implant-free, minimally invasive glaucoma surgery technologies (i) indicated in the United States to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The OMNI Surgical System is CE Marked for the catheterization and transluminal viscodilation of Schlemm's canal and cutting of the trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma. Glaucoma is the world's leading cause of irreversible blindness. The SION® Surgical System is a bladeless, manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The Company's TearCare® System is 510(k) cleared in the United States for the application of localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland disease (MGD), enabling clearance of gland obstructions by physicians to address the leading cause of dry eye disease. Visit for more information. Sight Sciences, the Sight Sciences logo, TearCare, and SmartLids are trademarks of Sight Sciences registered in the United States. OMNI and SION are trademarks of Sight Sciences registered in the United States, European Union and other territories. © 2025 Sight Sciences. All rights reserved. Media contact:pr@ Investor contact:Philip TaylorGilmartin in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
38 minutes ago
- Yahoo
Peloton Interactive, Inc. Announces Date of Fourth Quarter & Fiscal Year 2025 Earnings Release and Conference Call
NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) -- Peloton Interactive, Inc. (NASDAQ: PTON) will release its fourth quarter and fiscal year 2025 financial results before the U.S. stock market opens on Thursday, August 7, 2025. The company will host a conference call and live audio webcast to discuss the financial results at 8:30 a.m. (Eastern Time) that day. Peloton's management will answer select questions from retail and institutional investors that are related to the company's business updates and quarterly financial results. To submit a question for consideration, please use the questionnaire form. A live audio webcast of the conference call will be available on the company's investor relations website at For those unable to participate in the conference call live, a replay will be available on the company's investor relations page for 30 days. About PelotonPeloton (NASDAQ: PTON) provides Members with world-class equipment, ground-breaking software, expert human instruction, and the world's most supportive fitness community. Founded in 2012 and headquartered in New York City, Peloton has millions of Members across the US, UK, Canada, Germany, Australia, and Austria. For more information, visit Investor Relations Contact:James Marshinvestor@ Media Contact:Stephanie Tackachpress@ while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
38 minutes ago
- Yahoo
Kiniksa Pharmaceuticals to Report Second Quarter 2025 Financial Results on July 29, 2025
LONDON, July 24, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, July 29, 2025 at 8:30 a.m. Eastern Time to report its second quarter 2025 financial results and recent portfolio execution. A live webcast will be accessible through the Investors & Media section of the company's website at Individuals interested in participating in the call via telephone may register here. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the event will also be available on Kiniksa's website within approximately 48 hours after the event. About KiniksaKiniksa is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating diseases by discovering, acquiring, developing, and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. Kiniksa's portfolio of assets is based on strong biologic rationale or validated mechanisms and offers the potential for differentiation. For more information, please visit Kiniksa Investor & Media ContactJonathan Kirshenbaum(781) 829-3949jkirshenbaum@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data